Treatment of drug - resistant TB is 20 times more expensive than treatment of normal TB and is less successful — half the patients with the drug - resistant strain die.
Ravimiresistentse tuberkuloosi ravi on 20 korda kallim tavalise tuberkuloosi ravist ja see pole sugugi nii tõhus – pooled ravimiresistentset tuberkuloosi põdejatest surevad.